Taken together, these results demonstrate that liver-specific deletion of Thrap3 confers systemic protection against diet-induced obesity and NAFLD without affecting the expression of FA β-oxidation- and lipogenesis-associated genes. The gene discussed is THRAP3; the disease is obesity due to melanocortin 4 receptor deficiency.